752 related articles for article (PubMed ID: 31092409)
1. EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG; Andreoli L; Limper M; Amoura Z; Cervera R; Costedoat-Chalumeau N; Cuadrado MJ; Dörner T; Ferrer-Oliveras R; Hambly K; Khamashta MA; King J; Marchiori F; Meroni PL; Mosca M; Pengo V; Raio L; Ruiz-Irastorza G; Shoenfeld Y; Stojanovich L; Svenungsson E; Wahl D; Tincani A; Ward MM
Ann Rheum Dis; 2019 Oct; 78(10):1296-1304. PubMed ID: 31092409
[TBL] [Abstract][Full Text] [Related]
2. Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults.
Tektonidou MG; Andreoli L; Limper M; Tincani A; Ward MM
RMD Open; 2019; 5(1):e000924. PubMed ID: 31168416
[TBL] [Abstract][Full Text] [Related]
3. Management of antiphospholipid syndrome.
Tuthill JI; Khamashta MA
J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
6. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
Front Immunol; 2019; 10():1948. PubMed ID: 31475009
[No Abstract] [Full Text] [Related]
7. Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy.
Lee EE; Jun JK; Lee EB
J Korean Med Sci; 2021 Jan; 36(4):e24. PubMed ID: 33496084
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing and treating antiphospholipid syndrome: a consensus paper.
Limper M; de Leeuw K; Lely AT; Westerink J; Teng YKO; Eikenboom J; Otter S; Jansen AJG; V D Ree M; Spierings J; Kruyt ND; van der Molen R; Middeldorp S; Leebeek FWG; Bijl M; Urbanus RT
Neth J Med; 2019 Apr; 77(3):98-108. PubMed ID: 31012427
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.
Ruffatti A; Salvan E; Del Ross T; Gerosa M; Andreoli L; Maina A; Alijotas-Reig J; De Carolis S; Mekinian A; Bertero MT; Canti V; Brucato A; Bremme K; Ramoni V; Mosca M; Di Poi E; Caramaschi P; Galeazzi M; Tincani A; Trespidi L
Thromb Haemost; 2014 Oct; 112(4):727-35. PubMed ID: 25008944
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
Front Immunol; 2018; 9():864. PubMed ID: 29867924
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
12. Serological evolution in women with positive antiphospholipid antibodies.
Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
[TBL] [Abstract][Full Text] [Related]
13. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).
Cuadrado MJ; Bertolaccini ML; Seed PT; Tektonidou MG; Aguirre A; Mico L; Gordon C; Ruiz-Irastorza G; Egurbide MV; Gil A; Espinosa G; Houssiau F; Rahman A; Martin H; McHugh N; Galindo M; Akil M; Amigo MC; Murru V; Khamashta MA
Rheumatology (Oxford); 2014 Feb; 53(2):275-84. PubMed ID: 24097288
[TBL] [Abstract][Full Text] [Related]
14. Management of antiphospholipid antibody syndrome: a systematic review.
Lim W; Crowther MA; Eikelboom JW
JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic risk in the antiphospholipid syndrome.
Lim W
Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
[TBL] [Abstract][Full Text] [Related]
16. The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective.
Spinillo A; Bellingeri C; De Maggio I; Riceputi G; Pandolfi MP; Spada C; Alpini C; Montecucco C; Beneventi F
J Reprod Immunol; 2021 Jun; 145():103304. PubMed ID: 33677238
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
[TBL] [Abstract][Full Text] [Related]
19. The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategies.
Erkan D
Curr Rheumatol Rep; 2002 Oct; 4(5):379-86. PubMed ID: 12217241
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
